☰

cached image

Damien Thévenin, Ph.D. - Publications

Affiliations: 
2011- Chemistry Lehigh University, Bethlehem, PA, United States 
Area:
Membrane protein biophysics
Website:
http://www.lehigh.edu/~dat311/index.html
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ankrom ET, Dalesandro B, Pires MM, Thévenin D. Selective Recruitment of Antibodies to Cancer Cells and Immune Cell-mediated Killing via In Situ Click Chemistry. Chemmedchem. e202400356. PMID 39087480 DOI: 10.1002/cmdc.202400356  0.413
2024 Kelly JJ, Ankrom ET, Newkirk SE, Thévenin D, Pires MM. Targeted acidosis mediated delivery of antigenic MHC-binding peptides. Frontiers in Immunology. 15: 1337973. PMID 38665920 DOI: 10.3389/fimmu.2024.1337973  0.379
2023 Rizzo S, Thévenin D. Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization. Methods in Molecular Biology (Clifton, N.J.). 2743: 195-209. PMID 38147217 DOI: 10.1007/978-1-0716-3569-8_13  0.317
2023 Kelly JJ, Ankrom E, Thévenin D, Pires MM. Targeted Acidosis Mediated Delivery of Antigenic MHC-Binding Peptides. Biorxiv : the Preprint Server For Biology. PMID 37904977 DOI: 10.1101/2023.10.18.562409  0.38
2023 Rizzo S, Sikorski E, Park S, Im W, Vasquez-Montes V, Ladokhin AS, Thévenin D. Promoting the Activity of a Receptor Tyrosine Phosphatase with a Novel pH-responsive Transmembrane Agonist Inhibits Cancer-Associated Phenotypes. Protein Science : a Publication of the Protein Society. e4742. PMID 37515426 DOI: 10.1002/pro.4742  0.497
2022 Schwarz M, Rizzo S, Paz WE, Kresinsky A, Thévenin D, Müller JP. Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD. Frontiers in Oncology. 12: 1017947. PMID 36452504 DOI: 10.3389/fonc.2022.1017947  0.321
2022 Bloch E, Sikorski EL, Pontoriero D, Day EK, Berger BW, Lazzara MJ, Thévenin D. Correction: Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes. The Journal of Biological Chemistry. 298: 102416. PMID 36075137 DOI: 10.1016/j.jbc.2022.102416  0.645
2022 Vasquez-Montes V, Tyagi V, Sikorski E, Kyrychenko A, Freites JA, Thévenin D, Tobias DJ, Ladokhin AS. Ca -dependent interactions between lipids and the tumor-targeting peptide pHLIP. Protein Science : a Publication of the Protein Society. 31: e4385. PMID 36040255 DOI: 10.1002/pro.4385  0.314
2022 Rizzo S, Sikorski E, Hart W, Gerristen J, Lazzarra M, White F, Thévenin D. Development of Tumor-selective Transmembrane Peptides to Promote the Activity of the Receptor Protein Tyrosine Phosphatase J by Disrupting its Homodimerization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35552736 DOI: 10.1096/fasebj.2022.36.S1.R3882  0.434
2022 Sikorski EL, Wehr J, Ferraro NJ, Rizzo SM, Pires MM, Thévenin D. Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells. Chembiochem : a European Journal of Chemical Biology. PMID 35199442 DOI: 10.1002/cbic.202100521  0.711
2020 Wehr J, Sikorski EL, Bloch E, Feigman MS, Ferraro NJ, Baybutt TR, Snook AE, Pires MM, Thévenin D. pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity. Journal of Medicinal Chemistry. PMID 32196345 DOI: 10.1021/Acs.Jmedchem.0C00016  0.716
2019 Vasquez-Montes V, Gerhart J, Thévenin D, Ladokhin AS. Divalent Cations and Lipid Composition Modulate Membrane Insertion and Cancer-Targeting Action of pHLIP. Journal of Molecular Biology. PMID 31689432 DOI: 10.1016/J.Bpj.2019.11.1395  0.445
2019 Bloch E, Sikorski EL, Pontoriero D, Day EK, Berger BW, Lazzara MJ, Thévenin D. Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes. The Journal of Biological Chemistry. PMID 31676686 DOI: 10.1074/Jbc.Ra119.010229  0.698
2018 Gerhart J, Thevenin AF, Bloch E, King KE, Thévenin D. Inhibiting EGFR Dimerization and Signaling Through Targeted Delivery of a Juxtamembrane Domain Peptide Mimic. Acs Chemical Biology. PMID 30133245 DOI: 10.1021/Acschembio.8B00555  0.741
2017 Vasquez-Montes V, Gerhart J, King KE, Thévenin D, Ladokhin AS. Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant. Biochimica Et Biophysica Acta. PMID 29138065 DOI: 10.1016/J.Bbamem.2017.11.006  0.634
2017 Burns KE, Hensley H, Robinson MK, Thévenin D. Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells & Mouse Models. Molecular Pharmaceutics. PMID 28048942 DOI: 10.1021/Acs.Molpharmaceut.6B00847  0.443
2017 Vasquez-Montes V, Burns KE, Thevenin D, Ladokhin AS. Lipid Headgroups Modulate Conformational Switching during Membrane Insertion of Cancer-Targeting pHLIP Peptides Biophysical Journal. 112: 527. DOI: 10.1016/J.Bpj.2016.11.2853  0.446
2017 Burns KE, Hensley H, Robinson MK, Thévenin D. Selective Delivery of Auristatins to Cancer Cells and Tumors using pHLIP Biophysical Journal. 112: 526a. DOI: 10.1016/J.Bpj.2016.11.2845  0.476
2016 Burns KE, McCleerey TP, Thévenin D. pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates. Scientific Reports. 6: 28465. PMID 27334357 DOI: 10.1038/Srep28465  0.489
2015 Burns KE, Thévenin D. Down-Regulation of PAR1 Activity with a pHLIP-based Allosteric Antagonist Induces Cancer Cell Death. The Biochemical Journal. PMID 26424552 DOI: 10.1042/Bj20150876  0.573
2015 Janout V, Schell WA, Thévenin D, Yu Y, Perfect JR, Regen SL. Taming Amphotericin B. Bioconjugate Chemistry. 26: 2021-4. PMID 26340430 DOI: 10.1021/Acs.Bioconjchem.5B00463  0.351
2015 Burns KE, Robinson MK, Thévenin D. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates. Molecular Pharmaceutics. 12: 1250-8. PMID 25741818 DOI: 10.1021/Mp500779K  0.464
2015 Burns K, Robinson M, Thévenin D. Specific Delivery of Auristatins to Tumor Cells using pHLIP Biophysical Journal. 108: 83a. DOI: 10.1016/J.Bpj.2014.11.484  0.476
2015 Dembicer E, Watkins M, Thevenin D. Homo and Hetero Dimerization of Receptor Protein Tyrosine Phosphatases Biophysical Journal. 108: 258a. DOI: 10.1016/J.Bpj.2014.11.1427  0.426
2015 Gerhart J, Haddad-Weiser G, Kussrow A, Bornhop D, Flowers R, Thévenin D. Backscattering Interferometry: Seeing Membrane Proteins in a New Light Biophysical Journal. 108: 253a. DOI: 10.1016/J.Bpj.2014.11.1398  0.343
2014 Engelman DM, An M, Andreev OA, Barrera FN, Bahal R, Bosenberg MW, Cheng C, Glazer PM, Karabadzhak A, Reshetnyak YK, Saltzman WM, Slack FJ, Svoronos AA, Thevenin D. Imaging and Treating Tumors by Targeting their Acidity with Phlip, a Ph-Sensitve Insertion Peptide Biophysical Journal. 106: 231a. DOI: 10.1016/J.Bpj.2013.11.1350  0.697
2013 Li N, Yin L, Thévenin D, Yamada Y, Limmon G, Chen J, Chow VT, Engelman DM, Engelward BP. Peptide targeting and imaging of damaged lung tissue in influenza-infected mice. Future Microbiology. 8: 257-69. PMID 23374130 DOI: 10.2217/Fmb.12.134  0.513
2012 Thévenin D, Lazarova T. Identifying and measuring transmembrane helix-helix interactions by FRET. Methods in Molecular Biology (Clifton, N.J.). 914: 87-106. PMID 22976024 DOI: 10.1007/978-1-62703-023-6_6  0.39
2011 Matthews EE, Thévenin D, Rogers JM, Gotow L, Lira PD, Reiter LA, Brissette WH, Engelman DM. Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2234-44. PMID 21402716 DOI: 10.1096/Fj.10-178673  0.693
2010 Thévenin D, Matthews EE, Rogers JM, An M, Gotow L, Lira PD, Reiter LA, Brissette WH, Engelman DM. Involvement of Transmembrane Helix Dimerization and Rotation in Signaling by the Thrombopoietin Receptor Biophysical Journal. 98: 420a. DOI: 10.1016/J.Bpj.2009.12.2269  0.711
2009 Thévenin D, An M, Engelman DM. pHLIP-mediated translocation of membrane-impermeable molecules into cells. Chemistry & Biology. 16: 754-62. PMID 19635412 DOI: 10.1016/J.Chembiol.2009.06.006  0.699
2008 Thévenin D, Lazarova T. Stable interactions between the transmembrane domains of the adenosine A2A receptor. Protein Science : a Publication of the Protein Society. 17: 1188-99. PMID 18434504 DOI: 10.1110/Ps.034843.108  0.438
2005 Thévenin D, Roberts MF, Lazarova T, Robinson CR. Identifying interactions between transmembrane helices from the adenosine A2A receptor. Biochemistry. 44: 16239-45. PMID 16331984 DOI: 10.1021/Bi051422U  0.437
2005 Thévenin D, Lazarova T, Roberts MF, Robinson CR. Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor. Protein Science : a Publication of the Protein Society. 14: 2177-86. PMID 15987888 DOI: 10.1110/Ps.051409205  0.448
Show low-probability matches.